59
|
Gould PA, Gula LJ, Champagne J, Healey JS, Cameron D, Simpson C, Thibault B, Pinter A, Tung S, Sterns L, Birnie D, Exner D, Parkash R, Skanes AC, Yee R, Klein GJ, Krahn AD. Outcome of advisory implantable cardioverter-defibrillator replacement: One-year follow-up. Heart Rhythm 2008; 5:1675-81. [DOI: 10.1016/j.hrthm.2008.09.020] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/04/2008] [Accepted: 09/17/2008] [Indexed: 11/16/2022]
|
60
|
Swerdlow CD, Gunderson BD, Ousdigian KT, Abeyratne A, Stadler RW, Gillberg JM, Patel AS, Ellenbogen KA. Downloadable Algorithm to Reduce Inappropriate Shocks Caused by Fractures of Implantable Cardioverter-Defibrillator Leads. Circulation 2008; 118:2122-9. [DOI: 10.1161/circulationaha.108.796136] [Citation(s) in RCA: 118] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background—
The primary method for monitoring implantable cardioverter-defibrillator lead integrity is periodic measurement of impedance. Sprint Fidelis leads are prone to pace-sense lead fractures, which commonly present as inappropriate shocks caused by oversensing.
Methods and Results—
We developed and tested an algorithm to enhance early identification of lead fractures and to reduce inappropriate shocks. This lead-integrity algorithm, which can be downloaded into presently implanted implantable cardioverter-defibrillators, alerts the patient and/or physician when triggered by either oversensing or excessive increases in impedance. To reduce inappropriate shocks, the lead-integrity algorithm increases the number of intervals to detect (NID) ventricular fibrillation when triggered. The lead-integrity algorithm was tested on data from 15 970 patients with Fidelis leads (including 121 with clinically diagnosed fractures) and 95 other fractured leads confirmed by analysis of returned product. The effect of the NID on inappropriate shocks was tested in 92 patients with 927 shocks caused by lead fracture. Increasing the NID reduced inappropriate shocks (
P
<0.0001). The lead-integrity algorithm provided at least a 3-day warning of inappropriate shocks in 76% (95% CI, 66 to 84) of patients versus 55% (95% CI, 43 to 64) for optimal impedance monitoring (
P
=0.007). Its positive predictive value was 72% for lead fractures and 81% for lead fractures or header-connector problems requiring surgical intervention. The false-positive rate was 1 per 372 patient-years of monitoring.
Conclusions—
A lead-integrity algorithm developed for download into existing implantable cardioverter-defibrillators increases short-term warning of inappropriate shocks in patients with lead fractures and reduces the likelihood of inappropriate shocks. It is the first downloadable RAMware to enhance the performance of nominally functioning implantable cardioverter-defibrillators and the first implantable cardioverter-defibrillator monitoring feature that triggers real-time changes in ventricular fibrillation detection parameters to reduce inappropriate shocks.
Collapse
Affiliation(s)
- Charles D. Swerdlow
- From the Department of Cardiology Cedars–Sinai Medical Center, Los Angeles, Calif (C.D.S.); Medtronic, Inc, Mounds View, Minn (B.D.G., K.T.O., A.A., R.W.S., J.G., A.P.); and Division of Cardiology, Medical College of Virginia/Virginia Commonwealth University, Richmond (K.A.E.)
| | - Bruce D. Gunderson
- From the Department of Cardiology Cedars–Sinai Medical Center, Los Angeles, Calif (C.D.S.); Medtronic, Inc, Mounds View, Minn (B.D.G., K.T.O., A.A., R.W.S., J.G., A.P.); and Division of Cardiology, Medical College of Virginia/Virginia Commonwealth University, Richmond (K.A.E.)
| | - Kevin T. Ousdigian
- From the Department of Cardiology Cedars–Sinai Medical Center, Los Angeles, Calif (C.D.S.); Medtronic, Inc, Mounds View, Minn (B.D.G., K.T.O., A.A., R.W.S., J.G., A.P.); and Division of Cardiology, Medical College of Virginia/Virginia Commonwealth University, Richmond (K.A.E.)
| | - Athula Abeyratne
- From the Department of Cardiology Cedars–Sinai Medical Center, Los Angeles, Calif (C.D.S.); Medtronic, Inc, Mounds View, Minn (B.D.G., K.T.O., A.A., R.W.S., J.G., A.P.); and Division of Cardiology, Medical College of Virginia/Virginia Commonwealth University, Richmond (K.A.E.)
| | - Robert W. Stadler
- From the Department of Cardiology Cedars–Sinai Medical Center, Los Angeles, Calif (C.D.S.); Medtronic, Inc, Mounds View, Minn (B.D.G., K.T.O., A.A., R.W.S., J.G., A.P.); and Division of Cardiology, Medical College of Virginia/Virginia Commonwealth University, Richmond (K.A.E.)
| | - Jeffrey M. Gillberg
- From the Department of Cardiology Cedars–Sinai Medical Center, Los Angeles, Calif (C.D.S.); Medtronic, Inc, Mounds View, Minn (B.D.G., K.T.O., A.A., R.W.S., J.G., A.P.); and Division of Cardiology, Medical College of Virginia/Virginia Commonwealth University, Richmond (K.A.E.)
| | - Amisha S. Patel
- From the Department of Cardiology Cedars–Sinai Medical Center, Los Angeles, Calif (C.D.S.); Medtronic, Inc, Mounds View, Minn (B.D.G., K.T.O., A.A., R.W.S., J.G., A.P.); and Division of Cardiology, Medical College of Virginia/Virginia Commonwealth University, Richmond (K.A.E.)
| | - Kenneth A. Ellenbogen
- From the Department of Cardiology Cedars–Sinai Medical Center, Los Angeles, Calif (C.D.S.); Medtronic, Inc, Mounds View, Minn (B.D.G., K.T.O., A.A., R.W.S., J.G., A.P.); and Division of Cardiology, Medical College of Virginia/Virginia Commonwealth University, Richmond (K.A.E.)
| |
Collapse
|
61
|
Implantable cardioverter-defibrillator lead failure: how weak is the link? ACTA ACUST UNITED AC 2008; 5:758-9. [PMID: 18838965 DOI: 10.1038/ncpcardio1367] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2008] [Accepted: 08/11/2008] [Indexed: 11/09/2022]
Abstract
The implantable cardioverter-defibrillator (ICD) has been shown to decrease the risk of sudden cardiac death in patients when used for primary and secondary prevention. These devices are being used more frequently as indications for primary prevention broaden, and attention has become increasingly focused on complications caused by lead failure. A report using data from a large registry revealed that the cumulative incidence of lead malfunction that necessitated surgical revision of the ICD lead system was 2.5% over 5 years. A strategy to deal with failed leads by the implantation of new pace-sense leads or high-voltage leads resulted in a 20% malfunction recurrence rate at 5 years. Defibrillator leads have been termed the 'weakest link' in the ICD system. Further efforts from manufacturers, regulators, and implanting physicians are required to understand and address the causes of lead failure.
Collapse
|